Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs

Source

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.

Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs

Latest:

US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties

Anti-Coup Rebellion in Eastern Ukraine Completes 10 Years as Russian Forces Continue Advancing in Donetsk

April 2014 was a pivotal month for the people of the Donbass region in what was then still part of Ukraine. It was then that the governing regime was newly installed in Kiev by a coup d’état on February 20/21embarked on military hostilities against the people of the region. The coup overthrew Ukraine’s elected president and legislature. It sparked rebellion in Crimea, Donbass (Lugansk and Donetsk), and in towns and cities in other regions of eastern and southern Ukraine.

Anti-Coup Rebellion in Eastern Ukraine Completes 10 Years as Russian Forces Continue Advancing in Donetsk

Inflation and interest rates: the US experience

Once again the US Federal Reserve is in a quandary. Does it cut its policy interest rate soon in order to relieve pressure on debt servicing costs for consumers and businesses and perhaps avoid a stagflationary economy (ie low or no growth alongside higher inflation); or does it hold its current interest rate for borrowing in order to make sure inflation falls towards its target of 2% a year?

Inflation and interest rates: the US experience

China vs. the US: shipbuilding, subsidies, and the Jones Act

Hypocrisy thrives where double standards prevail.

Earlier, I stupidly tweeted out an article about the Jones Act and shipbuilding and Colin Grabow, from the Cato Institute, liked it (he was quoted in the article). I looked him up and decided to listen to this video on the shipbuilding competition between China and the US, where he and a lawyer for United Steelworkers were on the panel. China is eating their lunch, and it’s the ruling elites’ own fault, yet they scapegoat China for it. The double standards over China’s “unfair economic practices” AKA the subsidizing of their shipbuilding industry irritates me (liars irritate me even more). States give subsidies, grants, and tax breaks to corporations, all the time. Fincantieri Marinette Marine is just one example, but Wisconsin had done the same for Foxconn. Foxconn received tax breaks and $3B in subsidies, which was “the largest ever subsidy provided by a state to a foreign company”, despite not living up to their promises.

Rumble

Colin Grabow wants to end the Jones Act. I’ve made at least three video clips regarding the Jones Act, two with Sal Mercogliano from What’s Going On With Shipping and one from the government-funded CSIS (I’ve posted them, below). Spoiler alert: Sal says that the problem isn’t the Jones Act. Meanwhile, both CSIS and the Cato Institute (part of the Atlas Network) blame the Jones Act. Deregulation is a wet dream of big corporations (which fund both the Cato Institute and CSIS).

Read More »

Philippines’ ‘assertive transparency’ strategy is causing them to miss out economically

The Philippines is going all in with the United States and bracing itself against lost Chinese largesse. President Ferdinand Marcos Jnr will fly to Washington next month to attend the US-Japan-Philippines trilateral leaders’ summit. It will be his fourth visit to the US since taking office as president less than two years ago.

South China Sea: Philippines must softly manage disputes or miss out economically

Previously:

PH: Compared To China, US Trade, Investment Offers Laughable + More

SCS: The Office of Naval Research funded Stanford’s GKC